glp-1 prescriptions growth q1 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Strategies | Lockton

[16] Reported rates from trials include: Nausea: ~44% Vomiting: ~25% Diarrhea: ~31% Constipation: ~23% Dyspepsia: ~10% These effects reflect slowed gastric motility and are usually mild, but can lead to clinical implications: Dehydration Electrolyte abnormalities ED presentations for poor oral intake

Let us dive into these GLP-1-promoting foods that consequently help regulate your blood sugar and decrease your appetite

Hyperkalemia is a concern with potassium-enriched salt substitutes for individuals with CKD [22,38]

How to manage it: Eat smaller, more frequent meals to avoid overwhelming your digestive system

ABC News chief medical correspondent Dr

December 8, 2021